456 related articles for article (PubMed ID: 31766574)
1. Reversal of Epithelial-Mesenchymal Transition by Natural Anti-Inflammatory and Pro-Resolving Lipids.
Lee CH
Cancers (Basel); 2019 Nov; 11(12):. PubMed ID: 31766574
[TBL] [Abstract][Full Text] [Related]
2. Epithelial-mesenchymal transition: Initiation by cues from chronic inflammatory tumor microenvironment and termination by anti-inflammatory compounds and specialized pro-resolving lipids.
Lee CH
Biochem Pharmacol; 2018 Dec; 158():261-273. PubMed ID: 30389404
[TBL] [Abstract][Full Text] [Related]
3. Functional relevance of a six mesenchymal gene signature in epithelial-mesenchymal transition (EMT) reversal by the triple angiokinase inhibitor, nintedanib (BIBF1120).
Huang RY; Kuay KT; Tan TZ; Asad M; Tang HM; Ng AH; Ye J; Chung VY; Thiery JP
Oncotarget; 2015 Sep; 6(26):22098-113. PubMed ID: 26061747
[TBL] [Abstract][Full Text] [Related]
4. Diverse pathways of epithelial mesenchymal transition related with cancer progression and metastasis and potential effects of endocrine disrupting chemicals on epithelial mesenchymal transition process.
Lee HM; Hwang KA; Choi KC
Mol Cell Endocrinol; 2017 Dec; 457():103-113. PubMed ID: 28042023
[TBL] [Abstract][Full Text] [Related]
5. Induction of the Epithelial-to-Mesenchymal Transition of Human Colorectal Cancer by Human TNF-β (Lymphotoxin) and its Reversal by Resveratrol.
Buhrmann C; Yazdi M; Popper B; Kunnumakkara AB; Aggarwal BB; Shakibaei M
Nutrients; 2019 Mar; 11(3):. PubMed ID: 30917533
[TBL] [Abstract][Full Text] [Related]
6. Epithelial-mesenchymal, mesenchymal-epithelial, and endothelial-mesenchymal transitions in malignant tumors: An update.
Gurzu S; Turdean S; Kovecsi A; Contac AO; Jung I
World J Clin Cases; 2015 May; 3(5):393-404. PubMed ID: 25984514
[TBL] [Abstract][Full Text] [Related]
7. 3,5,4'-Trimethoxystilbene, a natural methoxylated analog of resveratrol, inhibits breast cancer cell invasiveness by downregulation of PI3K/Akt and Wnt/β-catenin signaling cascades and reversal of epithelial-mesenchymal transition.
Tsai JH; Hsu LS; Lin CL; Hong HM; Pan MH; Way TD; Chen WJ
Toxicol Appl Pharmacol; 2013 Nov; 272(3):746-56. PubMed ID: 23921149
[TBL] [Abstract][Full Text] [Related]
8. The epithelial to mesenchymal transition in pancreatic cancer: A systematic review.
Beuran M; Negoi I; Paun S; Ion AD; Bleotu C; Negoi RI; Hostiuc S
Pancreatology; 2015; 15(3):217-25. PubMed ID: 25794655
[TBL] [Abstract][Full Text] [Related]
9. Celecoxib and sulindac inhibit TGF-β1-induced epithelial-mesenchymal transition and suppress lung cancer migration and invasion via downregulation of sirtuin 1.
Cha BK; Kim YS; Hwang KE; Cho KH; Oh SH; Kim BR; Jun HY; Yoon KH; Jeong ET; Kim HR
Oncotarget; 2016 Aug; 7(35):57213-57227. PubMed ID: 27528025
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic implications of cancer epithelial-mesenchymal transition (EMT).
Cho ES; Kang HE; Kim NH; Yook JI
Arch Pharm Res; 2019 Jan; 42(1):14-24. PubMed ID: 30649699
[TBL] [Abstract][Full Text] [Related]
11. Curcumin: a potent agent to reverse epithelial-to-mesenchymal transition.
Bahrami A; Majeed M; Sahebkar A
Cell Oncol (Dordr); 2019 Aug; 42(4):405-421. PubMed ID: 30980365
[TBL] [Abstract][Full Text] [Related]
12. Integrative proteomic analysis reveals reprograming tumor necrosis factor signaling in epithelial mesenchymal transition.
Zhao Y; Tian B; Sadygov RG; Zhang Y; Brasier AR
J Proteomics; 2016 Oct; 148():126-38. PubMed ID: 27461979
[TBL] [Abstract][Full Text] [Related]
13. Combined treatment with zingerone and its novel derivative synergistically inhibits TGF-β1 induced epithelial-mesenchymal transition, migration and invasion of human hepatocellular carcinoma cells.
Kim YJ; Jeon Y; Kim T; Lim WC; Ham J; Park YN; Kim TJ; Ko H
Bioorg Med Chem Lett; 2017 Feb; 27(4):1081-1088. PubMed ID: 28110870
[TBL] [Abstract][Full Text] [Related]
14. Natural Plants Compounds as Modulators of Epithelial-to-Mesenchymal Transition.
Avila-Carrasco L; Majano P; Sánchez-Toméro JA; Selgas R; López-Cabrera M; Aguilera A; González Mateo G
Front Pharmacol; 2019; 10():715. PubMed ID: 31417401
[TBL] [Abstract][Full Text] [Related]
15. The role of the epithelial-to-mesenchymal transition (EMT) in diseases of the salivary glands.
Sisto M; Lisi S; Ribatti D
Histochem Cell Biol; 2018 Aug; 150(2):133-147. PubMed ID: 29789993
[TBL] [Abstract][Full Text] [Related]
16. Roles of Dietary Phytoestrogens on the Regulation of Epithelial-Mesenchymal Transition in Diverse Cancer Metastasis.
Lee GA; Hwang KA; Choi KC
Toxins (Basel); 2016 May; 8(6):. PubMed ID: 27231938
[TBL] [Abstract][Full Text] [Related]
17. Bovine lactoferrin reverses programming of epithelial-to-mesenchymal transition to mesenchymal-to-epithelial transition in oral squamous cell carcinoma.
Chea C; Miyauchi M; Inubushi T; Okamoto K; Haing S; Nguyen PT; Imanaka H; Takata T
Biochem Biophys Res Commun; 2018 Dec; 507(1-4):142-147. PubMed ID: 30415774
[TBL] [Abstract][Full Text] [Related]
18. Epithelial-mesenchymal transition (EMT) and metastasis: yes, no, maybe?
Diepenbruck M; Christofori G
Curr Opin Cell Biol; 2016 Dec; 43():7-13. PubMed ID: 27371787
[TBL] [Abstract][Full Text] [Related]
19. Pro-apoptotic Bax promotes mesenchymal-epithelial transition by binding to respiratory complex-I and antagonizing the malignant actions of pro-survival Bcl-2 proteins.
Kim EM; Jung CH; Song JY; Park JK; Um HD
Cancer Lett; 2018 Jun; 424():127-135. PubMed ID: 29596889
[TBL] [Abstract][Full Text] [Related]
20. Role of epithelial to mesenchymal transition in hepatocellular carcinoma.
Giannelli G; Koudelkova P; Dituri F; Mikulits W
J Hepatol; 2016 Oct; 65(4):798-808. PubMed ID: 27212245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
